Clinical trials
Recruiting Phase 1 Colorectal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
138 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 4 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 17 |
| 2024 | 33 |
| 2025 | 42 |
| 2026 | 32 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 138 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 7 |
| Eli Lilly and Company | 4 |
| Hefei TG ImmunoPharma Co., Ltd. | 3 |
| M.D. Anderson Cancer Center | 3 |
| Novartis Pharmaceuticals | 3 |
| AstraZeneca | 2 |
| Context Therapeutics Inc. | 2 |
| Hansoh BioMedical R&D Company | 2 |
| Hoffmann-La Roche | 2 |
| IDEAYA Biosciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 138 |
| Carcinoma, Non-Small-Cell Lung | 49 |
| Stomach Neoplasms | 28 |
| Neoplasm Metastasis | 26 |
| Pancreatic Neoplasms | 25 |
| Breast Neoplasms | 22 |
| Ovarian Neoplasms | 18 |
| Neoplasms | 16 |
| Triple Negative Breast Neoplasms | 16 |
| Squamous Cell Carcinoma of Head and Neck | 15 |
Trials
Showing 1 to 25 of 138. Each trial links to its page on Pharma Observatory.
38 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.